Evaluation du site timmermanreport.com
TimmermanReport.com - Your Edge In Biotech
Généré le 05 Avril 2026 03:40
Vieilles statistiques? UPDATE !
Le score est de 55/100
Optimisation du contenu
Titre
TimmermanReport.com - Your Edge In Biotech
Longueur : 42
Parfait, votre titre contient entre 10 et 70 caractères.
Description
Timmerman Report is an independently-owned subscription publication that provides timely, in-depth biotech news and analysis.
Longueur : 125
Génial, votre balise META description contient entre 70 et 160 caractères.
Mots-clefs
Très mauvais. Nous n'avons pas trouvé de balise META keywords sur votre page. Utilisez ce générateur gratuit de balises META en ligne pour créer des mots-clés.
Propriétés Open Graph
Bien, cette page profite des balises META Open Graph.
| Propriété | Contenu |
|---|---|
| locale | en_US |
| type | website |
| title | TimmermanReport.com - Your Edge In Biotech |
| description | Timmerman Report is an independently-owned subscription publication that provides timely, in-depth biotech news and analysis. |
| url | https://timmermanreport.com/ |
| site_name | Timmerman Report |
| image | https://timmermanreport.com/wp-content/uploads/2015/01/LittleTahoma.jpg |
| image:width | 800 |
| image:height | 600 |
Niveaux de titre
| H1 | H2 | H3 | H4 | H5 | H6 |
| 0 | 0 | 22 | 7 | 0 | 0 |
- [H3] Lilly Buys Centessa, Takeda & Alumis Tyk2 Showdown, & Blackstone’s Megafund
- [H3] Sleep Medicine Heats Up, as Lilly Enters Arena with Takeda, Alkermes
- [H3] Inspired by Mother Nature, Discovering New Drugs: Viswa Colluru on The Long Run
- [H3] Merck Snaps Up New Cancer Drug, Denali Grows Up, & Gilead’s TCE Wager
- [H3] Merck’s Davis-Era Acquisitions: Enough for Life After Keytruda?
- [H3] Europe’s Biotech Investment Crisis: Otello Stampacchia on The Long Run
- [H3] Servier Buys Day One, Vertex Hits IgAN Phase III, & Prasad’s Unceremonious Exit at FDA
- [H3] What the Timmerman Traverse Is All About
- [H3] Eli Lilly’s Last 20 Acquisitions, and the Opportunity for More
- [H3] Candid Goes Public, Uniqure’s FDA Dispute, & Moderna’s Big Legal Bill
- [H3] Biotech’s Deep Pool of Midsized Companies
- [H3] T-cell Engagers for Autoimmune Disease: Ken Song on The Long Run
- [H3] Agency: The Motivational Currency of Health
- [H3] Gilead Acquires Arcellx, Alkermes Passes the Torch, Beam Borrows Big
- [H3] Enjoy the Photos: Timmerman Traverse for Damon Runyon Kilimanjaro 2026
- [H3] FDA Flip-Flops on Flu Vaccine, Compass Passes Phase 3, & J&J Bets on Pennsylvania
- [H3] Discovering Drugs for Cancer and Autoimmunity: Ansu Satpathy
- [H3] Hike the High Sierras for Damon Runyon Cancer Research
- [H3] Gear Check: Timmerman Traverse for Damon Runyon Heads to Kilimanjaro
- [H3] Can We Ride the GenAI Wave Without Getting Subsumed by It?
- [H3] Your account
- [H3] What Readers Are Saying
- [H4] Download the Report
- [H4] Visit www.dash.bio
- [H4] Download the Report Here
- [H4] Two Visions of Primary Care
- [H4] Who’s in charge?
- [H4] A Company Built on What Matters
- [H4] Bottom Line
Images
Nous avons trouvé 71 image(s) sur cette page Web.
70 attribut(s) alt sont vides ou manquants. Ajouter un texte alternatif permet aux moteurs de recherche de mieux comprendre le contenu de vos images.
Ratio texte/HTML
Ratio : 19%
Bien, le ratio de cette page texte/HTML est supérieur à 15, mais inférieur à 25 pour cent.
Flash
Parfait, aucun contenu FLASH n'a été détecté sur cette page.
Iframe
Dommage, vous avez des Iframes sur vos pages Web, cela signifie que son contenu ne peut pas être indexé par les moteurs de recherche.
Liens
Réécriture d'URLs
Bien. Vos liens sont optimisés!
Tiret bas dans les URLs
Nous avons détectés des soulignements dans vos URLs. Vous devriez plutôt utiliser des tirets pour optimiser votre référencement.
Liens dans la page
Nous avons trouvé un total de 147 lien(s) dont 2 lien(s) vers des fichiers
| Texte d'ancre | Type | Juice |
|---|---|---|
| Traverse | Interne | Passing Juice |
| Timmerman Traverse for Damon Runyon – Sierras 2026 | Interne | Passing Juice |
| The Long Run Podcast | Interne | Passing Juice |
| About | Interne | Passing Juice |
| Speaking | Interne | Passing Juice |
| Events | Interne | Passing Juice |
| Team | Interne | Passing Juice |
| David Shaywitz | Interne | Passing Juice |
| Alex Harding | Interne | Passing Juice |
| Pedro Rafael Rosado | Interne | Passing Juice |
| Steve White | Interne | Passing Juice |
| In the News | Interne | Passing Juice |
| Testimonials | Interne | Passing Juice |
| Contact | Interne | Passing Juice |
| Subscribe | Interne | Passing Juice |
| Individual Subscriptions | Interne | Passing Juice |
| Group Subscriptions | Interne | Passing Juice |
| Lilly Buys Centessa, Takeda & Alumis Tyk2 Showdown, & Blackstone’s Megafund | Interne | Passing Juice |
| Luke Timmerman | Interne | Passing Juice |
| - | Interne | Passing Juice |
| All | Interne | Passing Juice |
| 02 Apr 2026 | Interne | Passing Juice |
| Sleep Medicine Heats Up, as Lilly Enters Arena with Takeda, Alkermes | Interne | Passing Juice |
| - | Interne | Passing Juice |
| 31 Mar 2026 | Interne | Passing Juice |
| Subscribe Now | Interne | Passing Juice |
| Sign in to your account. | Interne | Passing Juice |
| Inspired by Mother Nature, Discovering New Drugs: Viswa Colluru on The Long Run | Interne | Passing Juice |
| - | Interne | Passing Juice |
| Enveda | Externe | Passing Juice |
| The Long Run with Luke Timmerman | Externe | Passing Juice |
| Ep197: Viswa Colluru on Discovering Drugs Inspired by Mother Nature | Externe | Passing Juice |
| Merck Snaps Up New Cancer Drug, Denali Grows Up, & Gilead’s TCE Wager | Interne | Passing Juice |
| - | Interne | Passing Juice |
| 26 Mar 2026 | Interne | Passing Juice |
| Merck’s Davis-Era Acquisitions: Enough for Life After Keytruda? | Interne | Passing Juice |
| 1 | Interne | Passing Juice |
| 23 Mar 2026 | Interne | Passing Juice |
| Europe’s Biotech Investment Crisis: Otello Stampacchia on The Long Run | Interne | Passing Juice |
| - | Interne | Passing Juice |
| 17 Mar 2026 | Interne | Passing Juice |
| European Life Sciences Coalition | Externe | Passing Juice |
| Download the Report | Externe | Passing Juice |
| www.dash.bio | Externe | Passing Juice |
| Ep196: Otello Stampacchia on Europe’s Biotech Crisis | Externe | Passing Juice |
| Servier Buys Day One, Vertex Hits IgAN Phase III, & Prasad’s Unceremonious Exit at FDA | Interne | Passing Juice |
| - | Interne | Passing Juice |
| 12 Mar 2026 | Interne | Passing Juice |
| What the Timmerman Traverse Is All About | Interne | Passing Juice |
| - | Interne | Passing Juice |
| 11 Mar 2026 | Interne | Passing Juice |
| Eli Lilly’s Last 20 Acquisitions, and the Opportunity for More | Interne | Passing Juice |
| 1 | Interne | Passing Juice |
| 10 Mar 2026 | Interne | Passing Juice |
| Candid Goes Public, Uniqure’s FDA Dispute, & Moderna’s Big Legal Bill | Interne | Passing Juice |
| - | Interne | Passing Juice |
| 05 Mar 2026 | Interne | Passing Juice |
| Biotech’s Deep Pool of Midsized Companies | Interne | Passing Juice |
| - | Interne | Passing Juice |
| 04 Mar 2026 | Interne | Passing Juice |
| T-cell Engagers for Autoimmune Disease: Ken Song on The Long Run | Interne | Passing Juice |
| - | Interne | Passing Juice |
| 03 Mar 2026 | Interne | Passing Juice |
| in November 2021 | Interne | Passing Juice |
| alpha-sense.com/thelongrun | Externe | Passing Juice |
| Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases | Externe | Passing Juice |
| Agency: The Motivational Currency of Health | Interne | Passing Juice |
| David Shaywitz | Interne | Passing Juice |
| - | Interne | Passing Juice |
| 27 Feb 2026 | Interne | Passing Juice |
| here | Externe | Passing Juice |
| Lore Health | Externe | Passing Juice |
| KindWellHealth | Externe | Passing Juice |
| Gilead Acquires Arcellx, Alkermes Passes the Torch, Beam Borrows Big | Interne | Passing Juice |
| - | Interne | Passing Juice |
| 26 Feb 2026 | Interne | Passing Juice |
| Enjoy the Photos: Timmerman Traverse for Damon Runyon Kilimanjaro 2026 | Interne | Passing Juice |
| - | Interne | Passing Juice |
| 20 Feb 2026 | Interne | Passing Juice |
| Dendrosenecio kilimanjari | Externe | Passing Juice |
| Damon Runyon Cancer Research Foundation | Externe | Passing Juice |
| FDA Flip-Flops on Flu Vaccine, Compass Passes Phase 3, & J&J Bets on Pennsylvania | Interne | Passing Juice |
| - | Interne | Passing Juice |
| 19 Feb 2026 | Interne | Passing Juice |
| Discovering Drugs for Cancer and Autoimmunity: Ansu Satpathy | Interne | Passing Juice |
| - | Interne | Passing Juice |
| 17 Feb 2026 | Interne | Passing Juice |
| Download the Report Here | Externe | Passing Juice |
| Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery | Externe | Passing Juice |
| 1 | Interne | Passing Juice |
| 09 Feb 2026 | Interne | Passing Juice |
| LINK | Externe | Passing Juice |
| Tata Kavlashvili | Externe | Passing Juice |
| Shaohua Zhang | Externe | Passing Juice |
| Lachelle Weeks | Externe | Passing Juice |
| Antonio Laporte | Externe | Passing Juice |
| Natasha O’Brown | Externe | Passing Juice |
| Colin Magowan | Externe | Passing Juice |
| Mark Murcko | Externe | Passing Juice |
| Nadav Rosenberg | Externe | Passing Juice |
| Lisa Purcell | Externe | Passing Juice |
| David Kaufman | Externe | Passing Juice |
| Rob Crummet | Externe | Passing Juice |
| Michele LeSueur | Externe | Passing Juice |
| Carl Schoellhammer | Externe | Passing Juice |
| Tony Martignetti | Externe | Passing Juice |
| Krysta Pellegrino | Externe | Passing Juice |
| Thomas (Gus) Gustafson | Externe | Passing Juice |
| Vivek Mittal | Externe | Passing Juice |
| Anne Kasmar | Externe | Passing Juice |
| Henry Kilgore | Externe | Passing Juice |
| Hamza Sheikh | Externe | Passing Juice |
| Gear Check: Timmerman Traverse for Damon Runyon Heads to Kilimanjaro | Interne | Passing Juice |
| - | Interne | Passing Juice |
| Can We Ride the GenAI Wave Without Getting Subsumed by It? | Interne | Passing Juice |
| 1 | Interne | Passing Juice |
| Tools | Interne | Passing Juice |
| 08 Feb 2026 | Interne | Passing Juice |
| probably never | Externe | Passing Juice |
| released | Externe | Passing Juice |
| Reported | Externe | Passing Juice |
| used | Externe | Passing Juice |
| viral | Externe | Passing Juice |
| downloaded | Externe | Passing Juice |
| headline | Externe | Passing Juice |
| observed | Externe | Passing Juice |
| said | Externe | Passing Juice |
| Ethan Mollick | Externe | Passing Juice |
| series | Externe | Passing Juice |
| essay | Externe | Passing Juice |
| aspires to deliver | Externe | Passing Juice |
| recently backed | Externe | Passing Juice |
| pursued | Externe | Passing Juice |
| tempted | Externe | Passing Juice |
| discussed | Externe | Passing Juice |
| elsewhere | Interne | Passing Juice |
| news | Externe | Passing Juice |
| Unbound | Externe | Passing Juice |
| enhances | Externe | Passing Juice |
| works | Externe | Passing Juice |
| 2 | Interne | Passing Juice |
| 3 | Interne | Passing Juice |
| 84 | Interne | Passing Juice |
| E-mail me | Externe | Passing Juice |
| Privacy Policy | Interne | Passing Juice |
| Terms of Use | Interne | Passing Juice |
| Perception Builder | Externe | Passing Juice |
Mots-clefs
Nuage de mots-clefs
damon runyon cancer traverse biotech subscribe timmerman all more from
Cohérence des mots-clefs
| Mot-clef | Contenu | Titre | Mots-clefs | Description | Niveaux de titre |
|---|---|---|---|---|---|
| timmerman | 38 |  |
 |
|
|
| more | 26 | |
|
|
|
| cancer | 24 | |
|
|
|
| biotech | 20 | |
|
|
|
| runyon | 19 | |
|
|
|
Ergonomie
Url
Domaine : timmermanreport.com
Longueur : 19
Favicon
Génial, votre site web dispose d'un favicon.
Imprimabilité
Aucun style CSS pour optimiser l'impression n'a pu être trouvé.
Langue
Bien. Votre langue est : en.
Dublin Core
Cette page ne profite pas des métadonnées Dublin Core.
Document
Doctype
HTML 5
Encodage
Parfait. Votre charset est UTF-8.
Validité W3C
Erreurs : 0
Avertissements : 0
E-mail confidentialité
Attention! Au moins une adresse e-mail a été trouvée en texte clair. Utilisez une protection anti-spam gratuite pour cacher vos e-mails aux spammeurs.
HTML obsolètes
Génial! Nous n'avons pas trouvé de balises HTML obsolètes dans votre code.
Astuces vitesse
|
Excellent, votre site n'utilise pas de tableaux imbriqués. |
|
Mauvais, votre site web utilise des styles css inline. |
|
Mauvais, votre site web contient trop de fichiers CSS (plus de 4). |
|
Mauvais, votre site web contient trop de fichiers javascript (plus de 6). |
|
Dommage, votre site n'est pas optimisé avec gzip. |
Mobile
Optimisation mobile
|
Icône Apple |
|
Méta tags viewport |
|
Contenu FLASH |
Optimisation
Sitemap XML
Votre site web dispose d’une sitemap XML, ce qui est optimal.
| https://timmermanreport.com/sitemap_index.xml |
Robots.txt
https://timmermanreport.com/robots.txt
Votre site dispose d’un fichier robots.txt, ce qui est optimal.
Mesures d'audience
Votre site web dispose d’une outil d'analytics, ce qui est optimal.
Google Analytics |
PageSpeed Insights
Dispositif
Les catégories
Free SEO Testing Tool
Free SEO Testing Tool est un outil gratuit de référencement qui vous aidera à analyser vos pages web